申请人:WAN Zehong
公开号:US20130178488A1
公开(公告)日:2013-07-11
The present invention relates to novel compounds that inhibit Lp-PLA
2
activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA
2
, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema.